| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | VN1R4 TAS2R16 ADRA1D OR8U1 OR8B4 SSTR1 OR11H2 GPR176 OR1L1 CNR2 OR8U8 OR4E1 | 2.46e-08 | 884 | 36 | 12 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | VN1R4 TAS2R16 ERBB3 ERBB4 ADRA1D OR8U1 OR8B4 SSTR1 OR11H2 GPR176 OR1L1 CNR2 OR8U8 OR4E1 | 3.71e-08 | 1353 | 36 | 14 | GO:0004888 |
| GeneOntologyMolecularFunction | odorant binding | 3.09e-06 | 127 | 36 | 5 | GO:0005549 | |
| GeneOntologyMolecularFunction | neuregulin receptor activity | 9.47e-06 | 3 | 36 | 2 | GO:0038131 | |
| GeneOntologyMolecularFunction | neuregulin binding | 4.72e-05 | 6 | 36 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 1.10e-04 | 431 | 36 | 6 | GO:0004984 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 3.02e-07 | 547 | 36 | 9 | GO:0007606 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | VN1R4 TAS2R16 ADRA1D OR8U1 OR8B4 SSTR1 OR11H2 GPR176 OR1L1 CNR2 OR8U8 OR4E1 | 2.38e-06 | 1395 | 36 | 12 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of smell | 1.34e-05 | 465 | 36 | 7 | GO:0007608 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 1.76e-05 | 485 | 36 | 7 | GO:0050907 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 2.89e-05 | 524 | 36 | 7 | GO:0009593 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 5.63e-05 | 582 | 36 | 7 | GO:0050906 | |
| GeneOntologyBiologicalProcess | sensory perception | 7.05e-05 | 1072 | 36 | 9 | GO:0007600 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 9.32e-05 | 432 | 36 | 6 | GO:0050911 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 2.15e-04 | 722 | 36 | 7 | GO:0051606 | |
| GeneOntologyBiologicalProcess | mammary gland epithelial cell differentiation | 4.97e-04 | 19 | 36 | 2 | GO:0060644 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 7.04e-04 | 233 | 36 | 4 | GO:0050806 | |
| MousePheno | decreased transitional stage T3 B cell number | 7.09e-06 | 3 | 22 | 2 | MP:0010228 | |
| MousePheno | abnormal transitional stage T3 B cell morphology | 1.42e-05 | 4 | 22 | 2 | MP:0009921 | |
| Domain | GPCR_Rhodpsn_7TM | VN1R4 ADRA1D OR8U1 OR8B4 SSTR1 OR11H2 GPR176 OR1L1 CNR2 OR8U8 | 1.98e-07 | 670 | 34 | 10 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_2 | VN1R4 ADRA1D OR8U1 OR8B4 SSTR1 OR11H2 GPR176 OR1L1 CNR2 OR8U8 | 2.64e-07 | 691 | 34 | 10 | PS50262 |
| Domain | GPCR_Rhodpsn | VN1R4 ADRA1D OR8U1 OR8B4 SSTR1 OR11H2 GPR176 OR1L1 CNR2 OR8U8 | 2.67e-07 | 692 | 34 | 10 | IPR000276 |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.62e-06 | 685 | 34 | 9 | PS00237 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 1.93e-05 | 4 | 34 | 2 | IPR016245 | |
| Domain | 7tm_1 | 2.25e-05 | 677 | 34 | 8 | PF00001 | |
| Domain | GF_recep_IV | 4.80e-05 | 6 | 34 | 2 | PF14843 | |
| Domain | GF_recep_IV | 4.80e-05 | 6 | 34 | 2 | IPR032778 | |
| Domain | Furin-like | 6.72e-05 | 7 | 34 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 6.72e-05 | 7 | 34 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 6.72e-05 | 7 | 34 | 2 | IPR006211 | |
| Domain | Recep_L_domain | 6.72e-05 | 7 | 34 | 2 | PF01030 | |
| Domain | - | 6.72e-05 | 7 | 34 | 2 | 3.80.20.20 | |
| Domain | Furin_repeat | 4.83e-04 | 18 | 34 | 2 | IPR006212 | |
| Domain | FU | 4.83e-04 | 18 | 34 | 2 | SM00261 | |
| Domain | Olfact_rcpt | 6.77e-04 | 393 | 34 | 5 | IPR000725 | |
| Domain | 7TM_GPCR_Srsx | 1.10e-03 | 112 | 34 | 3 | SM01381 | |
| Domain | TyrKc | 1.12e-02 | 88 | 34 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.12e-02 | 88 | 34 | 2 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 1.34e-02 | 97 | 34 | 2 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.34e-02 | 97 | 34 | 2 | IPR008266 | |
| Domain | Pkinase_Tyr | 2.30e-02 | 129 | 34 | 2 | PF07714 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.67e-05 | 417 | 29 | 7 | M4072 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 3.03e-05 | 636 | 29 | 8 | M41834 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 2.22e-04 | 11 | 29 | 2 | MM15478 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 3.14e-04 | 13 | 29 | 2 | MM15320 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 3.14e-04 | 13 | 29 | 2 | M27729 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 3.66e-04 | 14 | 29 | 2 | MM14761 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 3.66e-04 | 14 | 29 | 2 | MM14531 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 3.74e-04 | 69 | 29 | 3 | M27113 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 4.22e-04 | 15 | 29 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 4.22e-04 | 15 | 29 | 2 | M27608 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 4.56e-04 | 178 | 29 | 4 | M2890 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 4.82e-04 | 16 | 29 | 2 | M570 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 5.38e-04 | 186 | 29 | 4 | MM15994 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 6.44e-04 | 83 | 29 | 3 | MM14819 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 9.20e-04 | 22 | 29 | 2 | M26929 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.01e-03 | 23 | 29 | 2 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 1.01e-03 | 23 | 29 | 2 | M18719 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 1.07e-03 | 389 | 29 | 5 | M14091 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 1.19e-03 | 25 | 29 | 2 | M47934 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 1.29e-03 | 26 | 29 | 2 | M29535 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 1.29e-03 | 26 | 29 | 2 | MM15501 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 1.60e-03 | 29 | 29 | 2 | M27756 | |
| Pathway | WP_GPCRS_NONODORANT | 2.03e-03 | 266 | 29 | 4 | MM15843 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 2.07e-03 | 33 | 29 | 2 | M39455 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 2.07e-03 | 33 | 29 | 2 | M27591 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 2.07e-03 | 33 | 29 | 2 | MM14523 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 2.47e-03 | 36 | 29 | 2 | MM15300 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 3.66e-03 | 44 | 29 | 2 | MM14520 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 3.93e-03 | 156 | 29 | 3 | M27097 | |
| Pathway | WP_ERBB_SIGNALING_PATHWAY | 4.00e-03 | 46 | 29 | 2 | MM15950 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 4.35e-03 | 48 | 29 | 2 | MM15479 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 4.71e-03 | 50 | 29 | 2 | M553 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 4.84e-03 | 168 | 29 | 3 | MM14785 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 5.47e-03 | 54 | 29 | 2 | M29742 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 5.67e-03 | 55 | 29 | 2 | M47952 | |
| Pubmed | The upgraded role of HER3 and HER4 receptors in breast cancer. | 1.04e-06 | 2 | 36 | 2 | 19481955 | |
| Pubmed | Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients. | 1.04e-06 | 2 | 36 | 2 | 18182100 | |
| Pubmed | Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients. | 1.04e-06 | 2 | 36 | 2 | 26254096 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 28851073 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 27536774 | ||
| Pubmed | Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. | 1.04e-06 | 2 | 36 | 2 | 26745281 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17969526 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 19390858 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 31400925 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 29111349 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 28653892 | ||
| Pubmed | Expression of ErbB3, ErbB4, and neuregulin-1 mRNA during tooth development. | 3.12e-06 | 3 | 36 | 2 | 12112465 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9516479 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 28304405 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9565587 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30637799 | ||
| Pubmed | An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels. | 3.12e-06 | 3 | 36 | 2 | 11867753 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22891299 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 18424286 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 7689552 | ||
| Pubmed | Expression and significance of HER family receptors in neuroblastic tumors. | 3.12e-06 | 3 | 36 | 2 | 21203803 | |
| Pubmed | Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. | 3.12e-06 | 3 | 36 | 2 | 25731189 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9851845 | ||
| Pubmed | ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma. | 3.12e-06 | 3 | 36 | 2 | 23333248 | |
| Pubmed | Expression and potential role of ErbB receptors in type II endometrial cancer. | 3.12e-06 | 3 | 36 | 2 | 23395558 | |
| Pubmed | High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer. | 3.12e-06 | 3 | 36 | 2 | 24901400 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16685269 | ||
| Pubmed | Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay. | 6.24e-06 | 4 | 36 | 2 | 24557338 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 19447869 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21203579 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 15733067 | ||
| Pubmed | Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue. | 6.24e-06 | 4 | 36 | 2 | 23991224 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 18985033 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 11425901 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 27069134 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 26648299 | ||
| Pubmed | Expression of heregulin, phosphorylated HER-2, HER-3 and HER-4 in HER-2 negative breast cancers. | 6.24e-06 | 4 | 36 | 2 | 19148499 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 8816440 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 22327010 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 26021752 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 22854050 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 17177598 | ||
| Pubmed | Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. | 6.24e-06 | 4 | 36 | 2 | 9168115 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 9771475 | ||
| Pubmed | Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours. | 6.24e-06 | 4 | 36 | 2 | 20204273 | |
| Pubmed | Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer. | 1.04e-05 | 5 | 36 | 2 | 25416285 | |
| Pubmed | An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells. | 1.04e-05 | 5 | 36 | 2 | 20227043 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 7589796 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 9019162 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 15254894 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 23723069 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 22554477 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 15682390 | ||
| Pubmed | Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway. | 1.04e-05 | 5 | 36 | 2 | 15524405 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 10572067 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 12939402 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 26886748 | ||
| Pubmed | Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. | 1.04e-05 | 5 | 36 | 2 | 12646923 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 23137868 | ||
| Pubmed | Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. | 1.04e-05 | 5 | 36 | 2 | 21407808 | |
| Pubmed | Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. | 1.04e-05 | 5 | 36 | 2 | 8643489 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 9342050 | ||
| Pubmed | Ligands for ErbB-family receptors encoded by a neuregulin-like gene. | 1.04e-05 | 5 | 36 | 2 | 9168114 | |
| Pubmed | Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids. | 1.56e-05 | 6 | 36 | 2 | 27782124 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 11278868 | ||
| Pubmed | Myocilin mediates myelination in the peripheral nervous system through ErbB2/3 signaling. | 1.56e-05 | 6 | 36 | 2 | 23897819 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 15358134 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 15496447 | ||
| Pubmed | LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. | 1.56e-05 | 6 | 36 | 2 | 15282549 | |
| Pubmed | The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival. | 1.56e-05 | 6 | 36 | 2 | 30083275 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 19609946 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 20126551 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 22504067 | ||
| Pubmed | A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. | 2.18e-05 | 7 | 36 | 2 | 20446891 | |
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 7477375 | ||
| Pubmed | Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions. | 2.18e-05 | 7 | 36 | 2 | 22493501 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 15306553 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 16488402 | ||
| Pubmed | Dynamic expression of Erbb pathway members during early mammary gland morphogenesis. | 2.91e-05 | 8 | 36 | 2 | 17960183 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 34714866 | ||
| Pubmed | Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4. | 3.73e-05 | 9 | 36 | 2 | 10655590 | |
| Pubmed | EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics. | 3.73e-05 | 9 | 36 | 2 | 28988771 | |
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 20881644 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 8702723 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 19298847 | ||
| Pubmed | Structural basis of cargo membrane protein discrimination by the human COPII coat machinery. | 4.66e-05 | 10 | 36 | 2 | 18843296 | |
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 25315821 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 10821760 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 17822758 | ||
| Pubmed | 8.07e-05 | 13 | 36 | 2 | 10707974 | ||
| Pubmed | An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. | 8.07e-05 | 13 | 36 | 2 | 21512138 | |
| Pubmed | Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6. | 8.84e-05 | 83 | 36 | 3 | 20029029 | |
| Pubmed | 1.08e-04 | 15 | 36 | 2 | 18760695 | ||
| Pubmed | Cdk5 phosphorylation of ErbB4 is required for tangential migration of cortical interneurons. | 1.24e-04 | 16 | 36 | 2 | 24142862 | |
| Pubmed | Chromosomal location-dependent nonstochastic onset of odor receptor expression. | 1.40e-04 | 17 | 36 | 2 | 20668191 | |
| Pubmed | 1.40e-04 | 17 | 36 | 2 | 22183742 | ||
| Pubmed | Jun and JunD-dependent functions in cell proliferation and stress response. | 1.40e-04 | 17 | 36 | 2 | 20300111 | |
| Pubmed | Phosphotyrosine interactome of the ErbB-receptor kinase family. | 1.76e-04 | 19 | 36 | 2 | 16729043 | |
| Pubmed | Notch signaling is essential for ventricular chamber development. | 3.60e-04 | 27 | 36 | 2 | 17336907 | |
| Pubmed | 5.72e-04 | 34 | 36 | 2 | 23293290 | ||
| Interaction | NPC1 interactions | 8.97e-06 | 364 | 28 | 6 | int:NPC1 | |
| Interaction | NRN1 interactions | 2.29e-05 | 40 | 28 | 3 | int:NRN1 | |
| Interaction | TMEM230 interactions | 3.50e-05 | 46 | 28 | 3 | int:TMEM230 | |
| Interaction | BTN2A3P interactions | 3.89e-05 | 7 | 28 | 2 | int:BTN2A3P | |
| Interaction | NRG2 interactions | 3.89e-05 | 7 | 28 | 2 | int:NRG2 | |
| Interaction | SELENOK interactions | 5.37e-05 | 53 | 28 | 3 | int:SELENOK | |
| Interaction | MUC4 interactions | 6.66e-05 | 9 | 28 | 2 | int:MUC4 | |
| Interaction | PTPN20 interactions | 1.68e-04 | 14 | 28 | 2 | int:PTPN20 | |
| Interaction | SMIM20 interactions | 1.68e-04 | 14 | 28 | 2 | int:SMIM20 | |
| Interaction | TMEM134 interactions | 2.50e-04 | 17 | 28 | 2 | int:TMEM134 | |
| Interaction | SHD interactions | 2.81e-04 | 18 | 28 | 2 | int:SHD | |
| Interaction | FATE1 interactions | 3.55e-04 | 100 | 28 | 3 | int:FATE1 | |
| Interaction | SHC4 interactions | 4.23e-04 | 22 | 28 | 2 | int:SHC4 | |
| Interaction | CLEC17A interactions | 4.63e-04 | 23 | 28 | 2 | int:CLEC17A | |
| Interaction | GPR42 interactions | 4.82e-04 | 111 | 28 | 3 | int:GPR42 | |
| Interaction | DUSP18 interactions | 5.04e-04 | 24 | 28 | 2 | int:DUSP18 | |
| Interaction | SLA2 interactions | 5.04e-04 | 24 | 28 | 2 | int:SLA2 | |
| Interaction | SOCS5 interactions | 5.04e-04 | 24 | 28 | 2 | int:SOCS5 | |
| Interaction | SH2B3 interactions | 5.48e-04 | 25 | 28 | 2 | int:SH2B3 | |
| Interaction | HSH2D interactions | 5.48e-04 | 25 | 28 | 2 | int:HSH2D | |
| Interaction | CRTAC1 interactions | 6.39e-04 | 27 | 28 | 2 | int:CRTAC1 | |
| Interaction | ZNF532 interactions | 6.39e-04 | 27 | 28 | 2 | int:ZNF532 | |
| Interaction | STAP1 interactions | 6.39e-04 | 27 | 28 | 2 | int:STAP1 | |
| Interaction | SLA interactions | 7.38e-04 | 29 | 28 | 2 | int:SLA | |
| Cytoband | 15q21.2 | 2.40e-04 | 29 | 36 | 2 | 15q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q21 | 2.66e-03 | 97 | 36 | 2 | chr14q21 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 1.29e-05 | 4 | 27 | 2 | 1096 | |
| GeneFamily | Olfactory receptors, family 8 | 5.23e-05 | 49 | 27 | 3 | 155 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.53e-06 | 155 | 35 | 4 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.59e-06 | 161 | 35 | 4 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | BAL-Severe-cDC_8|Severe / Compartment, Disease Groups and Clusters | 8.16e-06 | 164 | 35 | 4 | e8cbe7e01eca32886eb44e02d5333056b6bebc50 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 173 | 35 | 4 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-05 | 180 | 35 | 4 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-05 | 180 | 35 | 4 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-05 | 181 | 35 | 4 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-05 | 183 | 35 | 4 | 3ebe334ad570e3525341badb558f369c61daf3d3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 186 | 35 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 188 | 35 | 4 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-05 | 189 | 35 | 4 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 190 | 35 | 4 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 190 | 35 | 4 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-05 | 195 | 35 | 4 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-05 | 195 | 35 | 4 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Excitatory-eB(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | 51265e30f1138fd79733001d0db759f3dab0aaeb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.78e-05 | 200 | 35 | 4 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 139 | 35 | 3 | 2fb51abb3ce88c21726c026d6365b2582e2e79f6 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.95e-04 | 144 | 35 | 3 | 04f9054895be2275eecda687a6eeb02fa5ec69b9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 147 | 35 | 3 | c8e5bdc3538089acd35a4b41390afaec0ac6d1aa | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.11e-04 | 148 | 35 | 3 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-04 | 149 | 35 | 3 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-04 | 155 | 35 | 3 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.47e-04 | 156 | 35 | 3 | 896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.71e-04 | 161 | 35 | 3 | 7e0b8119cea208c0b4a0dffdf94ff6137d0b4c90 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.71e-04 | 161 | 35 | 3 | 3b5d7a3dab479c6959a428f3954dedd989900276 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.76e-04 | 162 | 35 | 3 | 2fd6e8f48b48d509a7533cec2f79089513c34a2f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.81e-04 | 163 | 35 | 3 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.86e-04 | 164 | 35 | 3 | 3caf4cdaa0164907893fea61e251fd8b5fa926e4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.91e-04 | 165 | 35 | 3 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.96e-04 | 166 | 35 | 3 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 3.07e-04 | 168 | 35 | 3 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.12e-04 | 169 | 35 | 3 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-04 | 171 | 35 | 3 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 172 | 35 | 3 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 172 | 35 | 3 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 173 | 35 | 3 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-04 | 173 | 35 | 3 | 5aa4d45a01d2d09eff8b4deb32bd91ab2471210a | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 173 | 35 | 3 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-04 | 173 | 35 | 3 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-04 | 174 | 35 | 3 | 2947e5906b172d149412fa4e77476fce4ea695d2 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 3.45e-04 | 175 | 35 | 3 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 175 | 35 | 3 | 06af6629766e2054e6995e8cdb3907658fec49d3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.51e-04 | 176 | 35 | 3 | e7502a345b2da83a9a60f50cf78f1aef385c99df | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-04 | 177 | 35 | 3 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 177 | 35 | 3 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 177 | 35 | 3 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-04 | 177 | 35 | 3 | 7e799333307448c6a94d1f33dbc59c543336f45e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 177 | 35 | 3 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 178 | 35 | 3 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-04 | 178 | 35 | 3 | a48739a588f361b4bc69405d7e256c11f61cf43c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-04 | 179 | 35 | 3 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 179 | 35 | 3 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.75e-04 | 180 | 35 | 3 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_GGT8P|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-04 | 181 | 35 | 3 | 9842537f9a607d8557c43790008d175edab1f32c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.87e-04 | 182 | 35 | 3 | 31efc06d6b073e8e341648207093e5f33c6f9183 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.87e-04 | 182 | 35 | 3 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.94e-04 | 183 | 35 | 3 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.00e-04 | 184 | 35 | 3 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.00e-04 | 184 | 35 | 3 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.00e-04 | 184 | 35 | 3 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 185 | 35 | 3 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 185 | 35 | 3 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 185 | 35 | 3 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | caf4f57f2db9ff72a652c8573e16e7ab180ffc05 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 185 | 35 | 3 | a1b2525da018abe458908cab7268bd403ee98d92 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | e2ba9f3518d87a44537a57a648df17ab98fbbb39 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-04 | 186 | 35 | 3 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.13e-04 | 186 | 35 | 3 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | fda3415222f688ef5cd8de4b0b79daa2493c585f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-04 | 186 | 35 | 3 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 187 | 35 | 3 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-04 | 187 | 35 | 3 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.19e-04 | 187 | 35 | 3 | baff4edc1bf64e3e03864a434fa47075ff7372fd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-04 | 188 | 35 | 3 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 188 | 35 | 3 | 3b8b9161f0fdcbde302ce5b4c0bc874628211109 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-04 | 188 | 35 | 3 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 188 | 35 | 3 | 794fc1d9a726945c42f7eac221eed938309b47a9 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-04 | 188 | 35 | 3 | c2101ded71fb16b8ddbc1f883911b1ed2a533ffc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-04 | 188 | 35 | 3 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-04 | 188 | 35 | 3 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-04 | 189 | 35 | 3 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-04 | 189 | 35 | 3 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 189 | 35 | 3 | a959c9d6a0866582688a4204d625c1e5a123e93d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.39e-04 | 190 | 35 | 3 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-04 | 190 | 35 | 3 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.46e-04 | 191 | 35 | 3 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.46e-04 | 191 | 35 | 3 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.46e-04 | 191 | 35 | 3 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 192 | 35 | 3 | bd3fa6c8fcb618db64d11f25cabaf08608957c35 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 192 | 35 | 3 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 192 | 35 | 3 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 4.53e-04 | 192 | 35 | 3 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 192 | 35 | 3 | 63d1b3efe93e5ff939278ebe40bacb38218ea09b | |
| Drug | 4-anilinoquinazoline | 1.53e-06 | 16 | 33 | 3 | CID000324081 | |
| Drug | N1-aminopropylagmatine | 4.19e-06 | 22 | 33 | 3 | CID000541551 | |
| Drug | PD168393 | 1.22e-05 | 4 | 33 | 2 | CID000004708 | |
| Drug | RG 14921 | 2.03e-05 | 5 | 33 | 2 | CID000197517 | |
| Drug | 6-quinolinecarbaldehyde | 2.03e-05 | 5 | 33 | 2 | CID000765653 | |
| Drug | SnCe6 | 3.04e-05 | 6 | 33 | 2 | CID000164259 | |
| Drug | Cochliobolic acid | 3.04e-05 | 6 | 33 | 2 | CID006450172 | |
| Drug | diethyl ester | 3.04e-05 | 6 | 33 | 2 | CID000264327 | |
| Drug | SSFSB | 4.26e-05 | 7 | 33 | 2 | CID003035734 | |
| Drug | RG 14467 | 4.26e-05 | 7 | 33 | 2 | CID000132069 | |
| Drug | D07907 | 5.84e-05 | 52 | 33 | 3 | CID011954378 | |
| Drug | CI-1033 | 6.19e-05 | 53 | 33 | 3 | CID000156413 | |
| Drug | indole-3-carbinol | 7.07e-05 | 154 | 33 | 4 | CID000003712 | |
| Drug | PC9 | 8.53e-05 | 59 | 33 | 3 | CID016040245 | |
| Drug | 6-(methylamino)pyrido(3,4-d)pyrimidine | 9.10e-05 | 10 | 33 | 2 | ctd:C107875 | |
| Drug | H 661 | 9.10e-05 | 10 | 33 | 2 | CID003056529 | |
| Drug | BE-23372M | 1.11e-04 | 11 | 33 | 2 | CID005311105 | |
| Drug | 4,5-dianilinophthalimide | 1.11e-04 | 11 | 33 | 2 | CID000001697 | |
| Drug | 2nq6 | 1.57e-04 | 13 | 33 | 2 | CID011809364 | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A | 1.69e-04 | 193 | 33 | 4 | 4623_DN | |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; PC3; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 4572_UP | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 6055_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 6096_UP | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 3220_DN | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 4838_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 6267_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 6228_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 5728_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 4765_DN | |
| Drug | 2aq7 | 2.11e-04 | 15 | 33 | 2 | CID005494446 | |
| Drug | propanedinitrile | 2.41e-04 | 16 | 33 | 2 | CID000008010 | |
| Disease | gallbladder neoplasm | 7.04e-05 | 11 | 34 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 7.04e-05 | 11 | 34 | 2 | C0153452 | |
| Disease | median neuropathy (biomarker_via_orthology) | 1.16e-04 | 14 | 34 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 2.18e-04 | 19 | 34 | 2 | DOID:2876 (is_marker_for) | |
| Disease | stomach carcinoma (is_marker_for) | 3.50e-04 | 24 | 34 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Breast Carcinoma | 3.56e-04 | 538 | 34 | 5 | C0678222 | |
| Disease | intestinal cancer (implicated_via_orthology) | 6.25e-04 | 32 | 34 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 8.37e-04 | 37 | 34 | 2 | DOID:0050865 (is_marker_for) | |
| Disease | ductal carcinoma in situ (is_marker_for) | 9.30e-04 | 39 | 34 | 2 | DOID:0060074 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.46e-03 | 195 | 34 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.46e-03 | 49 | 34 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | Orofacial cleft | 1.59e-03 | 51 | 34 | 2 | HP_0000202 | |
| Disease | Skin Neoplasms | 2.12e-03 | 59 | 34 | 2 | C0037286 | |
| Disease | Malignant neoplasm of skin | 2.12e-03 | 59 | 34 | 2 | C0007114 | |
| Disease | Bipolar Disorder | 2.13e-03 | 477 | 34 | 4 | C0005586 | |
| Disease | polycystic ovary syndrome | 2.19e-03 | 60 | 34 | 2 | EFO_0000660 | |
| Disease | transitional cell carcinoma (is_marker_for) | 2.41e-03 | 63 | 34 | 2 | DOID:2671 (is_marker_for) | |
| Disease | urolithiasis | 2.41e-03 | 63 | 34 | 2 | MONDO_0024647 | |
| Disease | carcinoma (implicated_via_orthology) | 2.48e-03 | 64 | 34 | 2 | DOID:305 (implicated_via_orthology) | |
| Disease | Alcohol abuse | 2.72e-03 | 67 | 34 | 2 | C0085762 | |
| Disease | Mammary Neoplasms, Human | 3.01e-03 | 525 | 34 | 4 | C1257931 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VIMIILMIPIAICIY | 251 | Q96KV6 | |
| AQPQICTIDVYMVMV | 931 | P21860 | |
| QPPICTIDVYMVMVK | 941 | Q15303 | |
| MRMLPSIIFTCIVYF | 481 | Q9UNQ0 | |
| TYSMVPIRVMVDLCN | 116 | Q6ZMI3 | |
| VCMLVFVVAMGVYRV | 841 | Q9H4D0 | |
| VMIIRCAKVIMDPYS | 31 | A0A1B0GTU2 | |
| MLCLINSMVNPVIYA | 286 | P34972 | |
| RYVAICNPLLYMVTM | 121 | Q96RC9 | |
| VVMCLVSIILYRAIM | 511 | Q6IWH7 | |
| LYMVVMTPGICIQLV | 131 | P0C7N1 | |
| PIQSMMCQYLARVLV | 131 | P09466 | |
| AVVSLCYSPLMVMYV | 261 | Q8NH07 | |
| MVMVFILCSVPYATL | 271 | Q14439 | |
| GMLLTCVVMFLVVQY | 196 | O14653 | |
| ICYVTVIIPKMLVNF | 121 | Q8NH94 | |
| RCFTIEYVMPMNTQL | 71 | Q9UF02 | |
| LQPEMCMVRKVIQFY | 1726 | Q9C0G6 | |
| LVQVIPVVARMIYEM | 391 | O14896 | |
| LYMVVMTPGICIQLV | 131 | Q8NH10 | |
| MIPIQLTVFFMIIYV | 1 | Q9NYV7 | |
| VVMVFVICWMPFYVV | 276 | P30872 | |
| PIFYIMFIIMIASCV | 246 | Q9H841 | |
| QMPLIFLYVVDTCME | 126 | Q15436 | |
| PMAVIVVMYCRVYVV | 266 | P25100 | |
| MVFPVMYNLIILVCR | 41 | Q8IV77 | |
| MVLFNFIIPVSMYVT | 351 | Q8NB49 | |
| GISFVIMCIFYMPTV | 11 | Q9P2K2 | |
| RYVAICKPLQYMIVM | 126 | P0C645 | |
| LYIMRVVQIAVMCVL | 51 | Q9NS64 | |
| KPVLALCVISYFVMM | 111 | Q15005 | |
| LCVISYFVMMGILTI | 116 | Q15005 | |
| KLIYFSVMSVCLMPV | 391 | Q8TCT8 | |
| IVCMLVNIIFPMYVT | 136 | Q7Z5H5 | |
| YGFMMLVLVILCIVT | 481 | Q9HD45 | |
| LCVEITMYSQMPVPV | 606 | P48553 | |
| FNMFVVIAVCIYVIP | 171 | Q9UPR5 |